NYHF 21st Forum:

Breaking into U.S Healthcare Market:

Collaborative Partnership Opportunities

November 28, 2022

6:00 PM – 9:30 PM

The Press Lounge - Greenhouse Room, Rooftop 16th Fl

​

New York City is home to the largest public healthcare system in the United States, with world-class private medical centers and a growing robust R&D landscape. Led by $1 billion initiative LifeSci NYC, the City’s investment in life sciences promises to create, produce and deliver dozens of new cures and treatments. This environment is ripe with opportunities for Korean and Korean American healthcare stakeholders to participate and leverage their positions.

 

 

A new path towards the future of critical patientcare is forged when physicians, pharmaceutical and medical device innovators, investors, healthcare regulators and policymakers work together globally. The New York Health Forum welcomes today’s healthcare leaders for a stimulating discussion on potential areas of growth and collaboration in 2023 and beyond.

 

Program

 

6:00-6:20 PM    Welcome Remarks

Sanghee Kim, Minister counselor at Embassy of the Republic of Korea

​

6:20-6:50 PM    Presentations

 

KHIDI & KHIDI USA roles in entering the U.S health industry

SoonmahnPark, PhD, President, KHIDI USA

 

The State of A.I. in New Drug Discovery and Development

Kilyoung Kim, PhD, President, Syntekabio USA

 

6:50-7:30 PM    Briefings

​

Introducing KAMPANY and Its Mission

Sanghyun Alex Kim, MD, President of KAMPANY

(Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai)

​

Opportunities and Challenges for the Korean Pharma Industry

Han S. Bang, US representative, ST Pharm (a Dong-A company)

​

Introduction to InnoTherapy technology

Peter Lee, Director, InnoTherapyAmerica Inc.

​

Genomics/Proteomics clinical research service provider

Seung Woo Song, VP, Psomagen

 

7:30PM -            Networking Dinner

​

​